article thumbnail

NHC Comments on Negotiation Data Elements and Drug Price Negotiation Process for Initial Price Applicability Year 2027 under Sections 11001 and 11002 of the IRA ICR Forms

Putting Patients First Blog

The NHC appreciates CMS’ efforts to gather patient-centered data as part of this ICR and its commitment to making the process more relevant for patients and patient organizations. While we acknowledge these improvements, it is important to note that some aspects of the data collection process may remain challenging.

article thumbnail

What Pharmacies Need to Know About Amazon RxPass, a $5/ Month Generic Drug Subscription

Digital Pharmacist

Amazon RxPass Benefits There’s no denying that RxPass presents some rather enticing benefits for Prime members, which now is estimated to include 172 million Americans. Another potential problem is that patients might be considered non-compliant by their insurance company if they fill their medications out of network (ie: using RxPass).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Making available more specific information about total costs and coverage will ensure that all consumers have comprehensive information to help them make smart health care decisions. These resources should aim to clarify insurance terms and concepts, aiding consumers in navigating the complexities of selecting a health plan.

article thumbnail

Biogen admits slow Aduhelm launch, as scientists question label again

pharmaphorum

.” He blamed the poor performance on ” confusion, misinformation and controversy surrounding our data and the approval process.” Analysts think sales will be lacklustre ahead of the outcome of a review of coverage by the Center for Medicare and Medicaid Services (CMS), which isn’t expected until next year.

article thumbnail

Frontiers Health Steering Committee spotlight: Eugene Borukhovich

pharmaphorum

In this latest coverage, pharmaphorum speaks with Eugene Borukhovich. He expects to see many new faces presenting, speaking in panel discussions, and much more: “That’s where you get the real deal information, right? The impacts of this, as we’ve seen, are insurers are on an acquisition spree at the moment,” Borukhovich says.

article thumbnail

Budget expectation: Bring GST rate on APIs at par with the formulations

Express Pharma

Expectation #2: Bring GST rate on APIs at par with the formulations – At present, APIs attract a higher GST rate of 18 per cent vis-à-vis formulations that attract a lower rate (12 per cent/5 per cent), leading to accumulation of credit for the pharma industry.

article thumbnail

ProxsysRx’s Meds To Beds Program Makes Immediate Impact Upon Launch At TMH

Proxsys Rx

Even with her insurance coverage, the co-pay was beyond her means. If it had been a large chain pharmacy, she would have essentially been presented with the option of paying a bill she couldn’t afford — or doing without. Our pharmacists were only too happy to help.